ADVERTISEMENT
US States
CRN’s attorneys ask Second Circuit for en banc review of a three-judge panel’s denial of its appeal of 2024 decision in district court rejecting motion for preliminary injunction against enforcement of New York state law age-restricting sales of weight loss and muscle building supplements.
Lawmakers in IL, MA and NJ as well as MI consider proposals as firms marketing weight loss and bodybuilding supplements in New York already are subject to first-ever state law limiting sales of products to consumers 18 and older.
Three-judge Second Circuit panel rejects CRN’s argument that New York General Business Law Section 391-oo, effective since April 2024 as first in US to prohibit sales of certain supplements to consumers under 18, violates First Amendment rights of supplement marketers.
Provision supported by Sen. Mitch McConnell, R-KY, along with House Appropriations Committee chair Andy Harris, R-MD, tightens definition of lawful hemp to exclude any THC derivative from cannabis at more than 0.3% concentration by dry weight and specifically exclude synthetics.
But the Senate’s reduction would not be as much as the House of Representatives and President Trump proposed earlier this year, which is likely a win for the agency.
Virgin Scent didn’t respond to NAD attorneys’ “repeated outreach attempts” asking for evidence supporting ad claims for Artnaturals NAD+ challenged by another NAD+ supplement marketer, Reus Research.
Dave Wendland retires after 34 years at HRG; AHPA science chief Holly Johnson earns WIN Guiding Star; Strategy, people leads for Vitamin Shoppe; CDMO Kenox appoints R&D, manufacturing VP; and contract manufacturer Radienz adds customer chief.
“Incredible rigor, thoughtfulness and discipline” went into Kleenex tissues, Huggies disposable diapers, and Kotex tampons marketer Kimberly-Clark’s $48.7bn offer for Kenvue, the former J&J consumer health products business on its own for two years.
In addition to Kenvue, complaint names as defendant J&J, which for decades marketed Tylenol oral analgesics before spinning Kenvue out in 2023. State asks court to order firms to pay $10,000 for each violation of state Deceptive Trade Practices-Consumer Protection Act.
BRS Analytical Services in St. Louis recalled more than 75,000 cases of redness and lubricating eye drops and committed “to permanently cease production of all drugs.”
National Advertising Division says XF Agencija permanently discontinued benefits and efficacy ad claims for Lunavia undecylenic acid 25% nail pen challenged by Advantice Health, marketer of Kerasal fungal nail renewal brand.
Testing network Certified Group names CFO; Brooke Burke a Power Life ambassador; Solarea names CEO; Welch’s appoints first brand, innovation chief; Deshanie Rai recognized as CRN/Radicle Science Trailblazer; first McGuffin award goes to Native Botanicals president.











